Treatment
Treatment A clinical trials
We’re tracking 8,312 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT03847649RecruitingPhase 2
Durvalumab for cancer after stopping immune therapy due to side effects
This Phase 2 trial tests whether durvalumab (an immunotherapy) can still help treat advanced cancer after you had to stop an earlier immune checkpoint medicine because of immune-related side effects. If you’re already on a durvalumab-based study, Substudy B also looks at continuing durvalumab (with or without tremelimumab) when it’s safe for you.
Edmonton, AlbertaAges 18 years+ - NCT03845205Recruiting
Liver transplant timing study for alcohol-related liver disease
This study compares early versus standard liver transplant timing for people whose liver illness was caused by alcohol use. It looks at treatment outcomes to see which approach helps patients do better.
Baltimore, MarylandAges 18 years+ - NCT03537794Recruiting
Brain scan study in treatment-resistant depression
This study compares brain synaptic density in people with treatment-resistant depression, people with depression that responds to treatment, and healthy controls. It uses a PET scan to measure synaptic density and aims to understand the biological differences.
Toronto, OntarioAges 25–65 - NCT03577041Recruiting
Cost study of eye injections for new macular degeneration
This study evaluates the cost-effectiveness of three anti-VEGF eye injection treatments (bevacizumab, ranibizumab, or aflibercept) for patients with newly diagnosed age-related macular degeneration affecting the center of vision. The research aims to understand which treatment option provides the best medical and financial value in France.
AmiensAges 18–70 - NCT03288948Recruiting
Binocular game therapy for lazy eye
This study tests a treatment that uses both eyes together (binocular games) to improve vision in children with “lazy eye” (amblyopia). It may help the weaker eye work better while the child practices at home and during study visits.
Dallas, TexasAges 4–10 - NCT02988128Recruiting
Medical device registry for Medtronic neurovascular products
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Buenos AiresAges 18 years+ - NCT02993029Recruiting
Fluoride scan–guided treatment for painful knee arthritis
This trial studies a targeted treatment using a fluoride-related injection to help reduce pain from knee osteoarthritis. To join, you need a painful osteoarthritis knee and a specific bone-scan finding (SUV above 10) on an imaging test.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT02804074Recruiting
Treat “hidden” high blood pressure using 24-hour monitoring
This study looks at better treatment for people whose blood pressure looks okay in the clinic, but stays high during daily life or at night. It uses 24-hour blood pressure monitoring (a test that checks readings throughout the day) to guide care and see if it helps control “masked uncontrolled” hypertension.
MilanAges 35–80 - NCT02437526Enrolling by invitation
Testing an HIV treatment pause to see if cure is possible
This study looks at whether some people with HIV can keep the virus controlled even if they temporarily stop HIV medicines (an “analytic treatment interruption”). If you qualify, it may help researchers learn what it would take for an HIV cure.
Rochester, MinnesotaAges 18 years+ - NCT00920972RecruitingPhase 1/Phase 2
Bone marrow transplant prep for children with non-cancer blood disorders
This early-stage study tests a specific chemotherapy “conditioning” regimen to prepare the body for a bone marrow transplant in children with certain non-cancer blood or immune conditions. It may help the transplant work better, but it also carries risks from the chemotherapy and transplant process.
Phoenix, ArizonaAges Up to 20 years - NCT07881861Recruiting
Walking test for knee osteoarthritis in women
This study looks at how a single session of walking on a treadmill affects cartilage health in the knees of women with osteoarthritis, and whether bone-strengthening medications change that response. Participants will walk for 30 minutes, and their knee fluid and blood will be checked.
Istanbul, IstanbulAges 60–80 - NCT07698886RecruitingPhase 2
Combination laser and gel for recurring genital warts
This trial tests a new gel applied after laser treatment to see if it reduces the chance of genital warts coming back. It may be an option for people who have had warts return after previous treatments.
Hanoi, None (International)Ages 18 years+ - NCT07828210RecruitingPhase 4
MLC901 for recovery after mild-to-moderate ischemic stroke
This trial tests a natural medicine called MLC901 (also known as NeuroAiD) to see if it helps patients recover better in the weeks after a mild-to-moderate ischemic stroke. The medicine is taken as an add-on to your usual care and may improve recovery when combined with rehabilitation.
Ho Chi Minh CityAges 18–80 - NCT07882394Recruiting
Alpha-lipoic acid as an add-on to gum treatment for gingivitis
This trial tests whether adding alpha-lipoic acid (an antioxidant) to standard non-surgical gum treatment helps reduce gingivitis (gum inflammation) better than the standard treatment alone. It aims to see if the combination is more effective for gum health.
IstanbulAges 18–65 - NCT07255066Recruiting
Omega-3 nutrition drink for advanced lung or colorectal cancer
This trial tests a special nutrition drink enriched with omega-3 (EPA) to see if it helps improve weight, inflammation, and quality of life in people with advanced lung or colorectal cancer. The drink is provided free, and you can continue your usual cancer treatment.
OsloAges 18 years+ - NCT06543550RecruitingPhase 4
Comparing implant and pill for endometriosis
This trial compares an implant that releases the hormone gestrinone with a daily pill called dienogest to see which works better for treating endometriosis symptoms. It might be a good option if you have mild to moderate endometriosis and are looking for a non-surgical treatment.
Campina Grande, ParaíbaAges 18–45 - NCT07884318Recruiting
Long-term safety study after investigational heart cell treatment
This study looks at the long-term safety of an experimental treatment called JRM-001, which uses a patient's own heart cells to help repair the heart after surgery for congenital heart disease. It is for children who previously took part in an earlier study of this treatment.
Okayama, Okayama-kenAges Any age - NCT07875478Recruiting
Tracking health and treatment for people with factor X deficiency
This study collects information from people with factor X deficiency and their family members to better understand how the condition affects people over time. It may help improve future care and treatment.
FlorenceAges Any age - NCT07881965RecruitingPhase 3
WS016 for lowering high potassium
This study tests an investigational medicine called WS016 to see if it can safely lower high potassium levels in the blood. High potassium can be dangerous, and this treatment may offer a new option to help manage it.
Anqing, AnhuiAges 18 years+ - NCT07883538Recruiting
Clascoterone vs adapalene for mild to moderate acne
This study compares two creams for mild to moderate acne: clascoterone and adapalene. You will be randomly assigned to one of the creams to see which works better for clearing acne.
Rawalpindi, Punjab ProvinceAges 12–55 - NCT05739734RecruitingPhase 1
Safety of CRT100 for spinal cord injury treatment
This trial tests a new medicine called CRT100 to see if it is safe for people with a recent spinal cord injury in the chest area. It may help with recovery from the injury.
São Paulo, São PauloAges 18–70 - NCT07703436RecruitingPhase 2
Safusidenib for people with IDH-mutant glioma whose tumor progressed on vorasidenib
This trial tests a new targeted therapy called safusidenib for people whose brain tumor (glioma) has an IDH1 mutation and who have already taken vorasidenib but the tumor kept growing. The study aims to see if safusidenib can help when vorasidenib stops working.
Los Angeles, CaliforniaAges 18 years+ - NCT07756645RecruitingPhase 3
Study of a new drug with chemotherapy for advanced lung cancer
This study tests a new drug called ABBV-1480 combined with chemotherapy for people with a type of lung cancer called squamous non-small cell lung cancer that has spread or cannot be removed with surgery. The goal is to see if it works as well as or better than the current standard treatment, pembrolizumab (also known as Keytruda) with chemotherapy.
Fort Wayne, IndianaAges 18 years+ - NCT05327894RecruitingPhase 3
Infants with a specific leukemia genetic change
This study tests a treatment plan for babies under 1 year with leukemia that has a KMT2A gene rearrangement. It may help by trying to improve outcomes in this high-risk group, sometimes using a drug called blinatumomab (depending on eligibility).
Buenos AiresAges 1 day–1 year
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.